Portfolio company
Glialign
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
Glialign develops engineered neural tissue to provide a living nerve-growth guide for the surgical repair of peripheral nerve injuries in patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Silk Biomaterials
This company develops silk-based implantable medical devices for tissue regeneration, including nerve conduits and vascular grafts, for clinicians and patients requiring surgical repair.
Newrotex
Newrotex develops silk-based conduits and fibres for surgeons to repair peripheral nerve injuries in patients suffering from trauma or surgery.
BE Therapeutics
This company develops engineered brain and spinal cord tissues to repair central nervous system damage for patients with neurodegeneration, stroke or trauma.
Neuromodulation
This company develops miniaturised peripheral nerve stimulation implants and wireless power systems to treat patients suffering from chronic neuropathic pain.
NeuroBionics
This company develops flexible bioelectronic fibers for endovascular neuromodulation to treat neurological and peripheral nerve disorders in patients without requiring invasive open-brain surgery.
Mangrove
Mangrove Neuro develops cell and tissue replacement therapies, including cortical grafts, to treat neurodegeneration and brain trauma for patients.
Neuro
Mangrove Neuro develops cell and tissue replacement therapies, specifically cortical grafts, for patients suffering from neurodegeneration and brain trauma.
Neurobioniocs
The company develops flexible bioelectronic fibers that deliver neuromodulation therapy through blood vessels for patients with neurological disorders.